EPTACOG BETA (Cevenfacta®)

Clinical Indication

For the treatment of bleeding episodes & prevention of bleeding in those undergoing surgery/invasive procedures

Date of classification

November 2022


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.